AGAPE ATP CORPORATION Operating Income
AGAPE ATP CORPORATION (ATPC) reported Operating Income of -$550.98 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-14
- AGAPE ATP CORPORATION operating income (loss) for the quarter ending 2026-06-30 was -$550.98K.
- AGAPE ATP CORPORATION operating income (loss) for the quarter ending 2026-03-31 was -$677.37K.
- AGAPE ATP CORPORATION operating income (loss) for the quarter ending 2025-12-31 was -$1.30M.
- AGAPE ATP CORPORATION operating income (loss) for the quarter ending 2025-09-30 was -$601.32K.
- AGAPE ATP CORPORATION operating income (loss) for fiscal 2025 was -$3.26M.
- AGAPE ATP CORPORATION operating income (loss) for fiscal 2024 was -$2.57M.
- AGAPE ATP CORPORATION operating income (loss) for fiscal 2023 was -$2.15M.
- AGAPE ATP CORPORATION operating income (loss) for fiscal 2022 was -$1.53M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$550.98K 10-Q · filed 2026-08-14 | -$1.20M 10-Q · filed 2026-08-14 | -$2.53M derived: sum of 3 quarters · filed 2026-08-14 | -$3.13M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | -$677.37K 10-Q · filed 2026-05-15 | -$1.98M derived: sum of 2 quarters · filed 2026-05-15 | -$2.58M derived: sum of 3 quarters · filed 2026-05-15 | -$3.20M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$1.90M derived: sum of 2 quarters · filed 2026-04-13 | -$2.52M derived: sum of 3 quarters · filed 2026-08-14 | -$3.26M 10-K · filed 2026-04-13 | ||
| 2025-09-30 | -$601.32K 10-Q · filed 2025-11-13 | -$1.22M derived: sum of 2 quarters · filed 2026-08-14 | -$1.96M 10-Q · filed 2025-11-13 | -$2.79M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | -$621.53K 10-Q · filed 2026-08-14 | -$636.96K 10-Q · filed 2025-08-13 | -$1.31M 10-Q · filed 2026-08-14 | -$1.36M 10-Q · filed 2025-08-13 | -$2.19M derived: sum of 3 quarters · filed 2026-08-14 | -$2.74M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$720.40K 10-Q · filed 2026-05-15 | -$1.57M derived: sum of 2 quarters · filed 2026-05-15 | -$2.12M derived: sum of 3 quarters · filed 2026-05-15 | -$2.57M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$848.11K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$1.40M derived: sum of 2 quarters · filed 2026-04-13 | -$1.85M derived: sum of 3 quarters · filed 2026-04-13 | -$2.57M 10-K · filed 2026-04-13 | ||
| 2024-09-30 | -$548.11K 10-Q · filed 2025-11-13 | -$1.00M derived: sum of 2 quarters · filed 2025-11-13 | -$1.73M 10-Q · filed 2025-11-13 | -$2.74M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$453.58K 10-Q · filed 2025-08-13 | -$1.18M 10-Q · filed 2025-08-13 | -$2.19M derived: sum of 3 quarters · filed 2025-08-13 | -$2.51M derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | -$723.54K 10-Q · filed 2025-05-15 | -$1.74M derived: sum of 2 quarters · filed 2025-05-15 | -$2.06M derived: sum of 3 quarters · filed 2025-05-15 | -$2.42M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.33M derived: sum of 2 quarters · filed 2025-03-31 | -$1.69M derived: sum of 3 quarters · filed 2025-03-31 | -$2.15M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | -$317.08K 10-Q · filed 2024-11-14 | -$676.61K derived: sum of 2 quarters · filed 2024-11-14 | -$1.13M 10-Q · filed 2024-11-14 | -$1.89M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$359.53K 10-Q · filed 2024-08-14 | -$813.42K 10-Q · filed 2024-08-14 | -$1.57M derived: sum of 3 quarters · filed 2024-08-14 | -$1.77M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$453.88K 10-Q · filed 2024-05-14 | -$1.22M derived: sum of 2 quarters · filed 2024-05-14 | -$1.41M derived: sum of 3 quarters · filed 2024-05-14 | -$1.71M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | -$761.54K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$954.85K derived: sum of 2 quarters · filed 2024-04-01 | -$1.26M derived: sum of 3 quarters · filed 2024-04-01 | -$1.53M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | -$193.31K 10-Q · filed 2023-11-14 | -$499.49K derived: sum of 2 quarters · filed 2023-11-14 | -$771.72K 10-Q · filed 2023-11-14 | -$1.51M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$306.18K 10-Q · filed 2023-08-14 | -$578.41K 10-Q · filed 2023-08-14 | -$1.32M derived: sum of 3 quarters · filed 2023-08-14 | -$1.69M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$272.23K 10-Q · filed 2023-05-15 | -$1.01M derived: sum of 2 quarters · filed 2023-05-15 | -$1.38M derived: sum of 3 quarters · filed 2023-05-15 | -$1.79M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$742.07K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$1.11M derived: sum of 2 quarters · filed 2023-03-31 | -$1.52M derived: sum of 3 quarters · filed 2023-03-31 | -$1.86M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | -$365.00K 10-Q · filed 2022-11-14 | -$773.99K derived: sum of 2 quarters · filed 2022-11-14 | -$1.12M 10-Q · filed 2022-11-14 | -$1.57M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$409.00K 10-Q · filed 2022-08-11 | -$751.51K 10-Q · filed 2022-08-11 | -$1.21M derived: sum of 3 quarters · filed 2022-08-11 | -$796.32K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$342.51K 10-Q · filed 2022-05-13 | -$797.97K derived: sum of 2 quarters · filed 2022-07-05 | -$387.32K derived: sum of 3 quarters · filed 2022-07-05 | -$341.13K derived: sum of 4 quarters · filed 2022-07-05 | ||
| 2020-12-31 | -$455.46K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | -$44.81K derived: sum of 2 quarters · filed 2022-07-05 | $1.38K derived: sum of 3 quarters · filed 2022-07-05 | -$158.13K 10-K/A · filed 2022-07-05 | ||
| 2020-09-30 | $410.65K 10-Q/A · filed 2022-07-05 | $456.84K derived: sum of 2 quarters · filed 2022-07-05 | $297.32K 10-Q/A · filed 2022-07-05 | $107.77K derived: sum of 4 quarters · filed 2022-07-05 | ||
| 2020-06-30 | $46.19K 10-Q · filed 2021-08-13 | -$113.32K 10-Q · filed 2021-08-13 | -$302.88K derived: sum of 3 quarters · filed 2021-08-13 | -$379.71K derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | -$159.52K 10-Q · filed 2021-05-17 | -$349.07K derived: sum of 2 quarters · filed 2021-05-17 | -$425.90K derived: sum of 3 quarters · filed 2021-05-17 | -$485.84K derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | -$189.56K derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-31 | -$266.39K 10-K · filed 2021-03-31 | -$326.32K derived: sum of 3 quarters · filed 2021-03-31 | -$314.59K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | -$76.83K 10-Q · filed 2020-11-16 | -$136.77K derived: sum of 2 quarters · filed 2020-11-16 | -$125.03K 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | -$59.94K 10-Q · filed 2020-08-13 | -$48.20K 10-Q · filed 2020-08-13 | -$131.17K 10-K · filed 2020-03-27 | |||
| 2019-03-31 | $15.89K 10-Q · filed 2020-05-14 | |||||
| 2018-12-31 | $2.87K 10-K · filed 2020-03-27 | |||||
| 2018-06-30 | -$234.09K 10-K · filed 2020-03-27 | |||||
| 2017-09-30 | $45.89K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |